# Immunologic Responses to a Live Attenuated Oral Cholera Vaccine

> **NCT03251495** · PHASE2 · COMPLETED · sponsor: **Emory University** · enrollment: 34 (actual)

## Conditions studied

- Cholera

## Interventions

- **DRUG:** Vaxchora

## Key facts

- **NCT ID:** NCT03251495
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-29
- **Primary completion:** 2024-12-10
- **Final completion:** 2025-11-06
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2026-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03251495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03251495, "Immunologic Responses to a Live Attenuated Oral Cholera Vaccine". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03251495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*